| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Hitoshi Morikawa, Richard A Morriset. Ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs. International review of neurobiology. vol 91. 2010-12-21. PMID:20813245. |
ethanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs. |
2010-12-21 |
2023-08-12 |
Not clear |
| Michael A Nitsche, Katia Monte-Silva, Min-Fang Kuo, Walter Paulu. Dopaminergic impact on cortical excitability in humans. Reviews in the neurosciences. vol 21. issue 4. 2010-12-10. PMID:21086761. |
the neurotransmitter has a non-linear dose-dependent effect on cortical excitability and activity, which depends on spontaneous activity, dopamine concentration, and dopaminergic sub-receptors, amongst others. |
2010-12-10 |
2023-08-12 |
human |
| Klaus Tatsc. Positron emission tomography in diagnosis and differential diagnosis of Parkinson's disease. Neuro-degenerative diseases. vol 7. issue 5. 2010-11-04. PMID:20616567. |
the more widely applied pet imaging techniques have focused on the assessment of neurotransmitter systems, here predominantly the pre- and postsynaptic dopaminergic functions, but also others like the serotonergic and cholinergic system. |
2010-11-04 |
2023-08-12 |
Not clear |
| Oskar Ortiz, José María Delgado-García, Isabel Espadas, Amine Bahí, Ramón Trullas, Jean-Luc Dreyer, Agnès Gruart, Rosario Moratall. Associative learning and CA3-CA1 synaptic plasticity are impaired in D1R null, Drd1a-/- mice and in hippocampal siRNA silenced Drd1a mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 30. issue 37. 2010-10-25. PMID:20844125. |
both glutamatergic and dopaminergic neurotransmitter systems have been implicated in learning and memory consolidation. |
2010-10-25 |
2023-08-12 |
mouse |
| Henry R Kranzler, Howard J Edenber. Pharmacogenetics of alcohol and alcohol dependence treatment. Current pharmaceutical design. vol 16. issue 19. 2010-10-08. PMID:20482509. |
we consider four neurotransmitter systems: opioidergic, dopaminergic, gabaergic, and glutamatergic and focus on one receptor protein in each: oprm1 (the &#micro;-opioid receptor gene), drd4 (the d(4) dopamine receptor gene), gabra2 (gaba(a) receptor alpha-2 subunit gene), and grik1 (the kainite receptor glur5 subunit gene). |
2010-10-08 |
2023-08-12 |
Not clear |
| T Fitzpatrick, P Mattis, D Eidelber. Functional imaging of cognitive impairment in Parkinson's disease. Clinical EEG and neuroscience. vol 41. issue 3. 2010-09-29. PMID:20722344. |
furthermore, insights gained from the use of specific radiotracers in the dopaminergic and cholinergic neurotransmitter systems are discussed, as well as findings from in vivo detection of amyloid-beta. |
2010-09-29 |
2023-08-12 |
Not clear |
| Ahmadul Kadir, Agneta Nordber. Target-specific PET probes for neurodegenerative disorders related to dementia. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. vol 51. issue 9. 2010-09-27. PMID:20810758. |
functional imaging such as pet allows in vivo imaging of functional brain activity indicating cerebral blood flow and cerebral glucose metabolism, and pet allows imaging of neurotransmitter activity, including that of the cholinergic, dopaminergic, and serotonergic systems. |
2010-09-27 |
2023-08-12 |
Not clear |
| Dominik Strzelecki, Jolanta Rabe-Jabłońsk. [Could we use a serum level of glycine as a prognostic factor of its efficacy in schizophrenic patients?]. Psychiatria polska. vol 44. issue 3. 2010-09-21. PMID:20672518. |
the ionotropic glutamatergic nmdareceptor participates in mechanisms of controlling neurotransmitter systems such as the dopaminergic, noradrenergic, serotoninergic ones and plays an important role in cognitive functioning. |
2010-09-21 |
2023-08-12 |
Not clear |
| D Rujescu, I Gieglin. The genetics of neurosystems in mental ill-health and suicidality: beyond serotonin. European psychiatry : the journal of the Association of European Psychiatrists. vol 25. issue 5. 2010-09-20. PMID:20392608. |
the dopaminergic and noradrenergic neurotransmitter systems have also been the subject of investigations in this context. |
2010-09-20 |
2023-08-12 |
human |
| Borwin Bandelow, Christian Schmahl, Peter Falkai, Dirk Wedekin. Borderline personality disorder: a dysregulation of the endogenous opioid system? Psychological review. vol 117. issue 2. 2010-09-14. PMID:20438240. |
dysfunctions of several neurobiological systems, including serotoninergic, dopaminergic, and other neurotransmitter systems, have been discussed. |
2010-09-14 |
2023-08-12 |
human |
| Yien-Ming Kuo, Zhishan Li, Yun Jiao, Nathalie Gaborit, Amar K Pani, Bonnie M Orrison, Benoit G Bruneau, Benoit I Giasson, Richard J Smeyne, Michael D Gershon, Robert L Nussbau. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Human molecular genetics. vol 19. issue 9. 2010-08-25. PMID:20106867. |
the a53t line also has abnormal motor behavior but neither demonstrates cardiac autonomic abnormalities, olfactory dysfunction, dopaminergic neurotransmitter deficits, lewy body inclusions or neurodegeneration. |
2010-08-25 |
2023-08-12 |
mouse |
| Catharine A Winstanley, Fiona D Zeeb, Amanda Bedard, Kent Fu, Barbara Lai, Christina Steele, Adeline C Won. Dopaminergic modulation of the orbitofrontal cortex affects attention, motivation and impulsive responding in rats performing the five-choice serial reaction time task. Behavioural brain research. vol 210. issue 2. 2010-08-10. PMID:20206211. |
dopaminergic activity within the ofc may therefore modulate impulsivity indirectly, perhaps in conjunction with other neurotransmitter systems. |
2010-08-10 |
2023-08-12 |
rat |
| Gil D Rabinovici, Bruce L Mille. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS drugs. vol 24. issue 5. 2010-06-25. PMID:20369906. |
current pharmacotherapy for ftld focuses on manipulating serotonergic or dopaminergic neurotransmitter systems to ameliorate behavioural or motor symptoms. |
2010-06-25 |
2023-08-12 |
Not clear |
| Hai-Ying Shen, Jiang-Fan Che. Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition. Current neuropharmacology. vol 7. issue 3. 2010-06-18. PMID:20190961. |
the adenosine a(2a) receptor (a(2a)r) is in the center of a neuromodulatory network affecting a wide range of neuropsychiatric functions by interacting with and integrating several neurotransmitter systems, especially dopaminergic and glutamatergic neurotransmission. |
2010-06-18 |
2023-08-12 |
Not clear |
| Peter N C Mohr, Shu-Chen Li, Hauke R Heekere. Neuroeconomics and aging: neuromodulation of economic decision making in old age. Neuroscience and biobehavioral reviews. vol 34. issue 5. 2010-06-02. PMID:19501615. |
the dopaminergic and serotoninergic brain systems have been identified as key neurotransmitter systems involved in economic behavior. |
2010-06-02 |
2023-08-12 |
Not clear |
| Rachael D Seidler, Jessica A Bernard, Taritonye B Burutolu, Brett W Fling, Mark T Gordon, Joseph T Gwin, Youngbin Kwak, David B Lipp. Motor control and aging: links to age-related brain structural, functional, and biochemical effects. Neuroscience and biobehavioral reviews. vol 34. issue 5. 2010-06-02. PMID:19850077. |
correspondingly, degeneration of neurotransmitter systems-primarily the dopaminergic system-may contribute to age-related gross and fine motor declines, as well as to higher cognitive deficits. |
2010-06-02 |
2023-08-12 |
Not clear |
| Maarten van den Buus. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophrenia bulletin. vol 36. issue 2. 2010-06-02. PMID:19900963. |
mouse models of dopaminergic and glutamatergic dysfunction are then discussed, reflecting the most important and widely studied neurotransmitter systems in schizophrenia. |
2010-06-02 |
2023-08-12 |
mouse |
| H J Waldvogel, K Baer, R L M Faul. The localization of inhibitory neurotransmitter receptors on dopaminergic neurons of the human substantia nigra. Journal of neural transmission. Supplementum. issue 73. 2010-05-14. PMID:20411768. |
the localization of inhibitory neurotransmitter receptors on dopaminergic neurons of the human substantia nigra. |
2010-05-14 |
2023-08-12 |
human |
| Ted Reichborn-Kjenneru. The genetic epidemiology of personality disorders. Dialogues in clinical neuroscience. vol 12. issue 1. 2010-04-26. PMID:20373672. |
molecular genetic studies of pds, mostly candidate gene association studies, indicate that genes linked to neurotransmitter pathways, especially in the serotonergic and dopaminergic systems, are involved. |
2010-04-26 |
2023-08-12 |
Not clear |
| Anne K Meyer, Martina Maisel, Andreas Hermann, Katja Stirl, Alexander Storc. Restorative approaches in Parkinson's Disease: which cell type wins the race? Journal of the neurological sciences. vol 289. issue 1-2. 2010-04-05. PMID:19733367. |
parkinson's disease (pd) is a progressive neurodegenerative movement disorder and is characterized by a continuous and selective loss of dopaminergic neurons in the midbrain with a subsequent reduction of the neurotransmitter dopamine in the striatum. |
2010-04-05 |
2023-08-12 |
Not clear |